These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8161669)

  • 41. Effects of omeprazole and lansoprazole on fasting and postprandial serum gastrin and serum pepsinogen A and C.
    Iwao T; Toyonaga A; Kuboyama S; Tanikawa K
    Hepatogastroenterology; 1995; 42(5):677-82. PubMed ID: 8751234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of omeprazole on intragastric pH, intestinal motility, and gastric emptying rate.
    Rasmussen L; Oster-Jørgensen E; Qvist N; Pedersen SA
    Scand J Gastroenterol; 1999 Jul; 34(7):671-5. PubMed ID: 10466877
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical study on the pathophysiology and treatment of PPI-resistant ulcers.
    Ashida K; Sakaguchi M; Tanaka M; Takiuchi H; Egashira Y; Katsu K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S67-71. PubMed ID: 7594345
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
    Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of ethanol ingestion on postprandial gastric emptying and secretion, biliopancreatic secretions, and duodenal absorption in man.
    Jian R; Cortot A; Ducrot F; Jobin G; Chayvialle JA; Modigliani R
    Dig Dis Sci; 1986 Jun; 31(6):604-14. PubMed ID: 3709325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Postprandial biliary and pancreatic secretion during profound inhibition of gastric secretion in humans.
    Lanzini A; Facchinetti D; Pigozzi MG; Wuhrer A; Saleri A
    Gut; 1993 Nov; 34(11):1607-11. PubMed ID: 8244151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of rabeprazole, lansoprazole, and ranitidine for improving preoperative gastric fluid property in adults undergoing elective surgery.
    Nishina K; Mikawa K; Takao Y; Shiga M; Maekawa N; Obara H
    Anesth Analg; 2000 Mar; 90(3):717-21. PubMed ID: 10702463
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determining the optimal dose of lansoprazole injection by 24-hour intragastric pH monitoring.
    Sugiyama M; Aoki T; Matsuo Y
    J Clin Gastroenterol; 1995; 20 Suppl 2():S14-6. PubMed ID: 7594331
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome.
    Hirschowitz BI; Mohnen J; Shaw S
    Aliment Pharmacol Ther; 1996 Aug; 10(4):507-22. PubMed ID: 8853754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibitory effects of intravenous lansoprazole on gastric acid hypersecretion in patients with postoperative stress.
    Otani Y; Kitajima M; Sugiyama M; Watanabe Y; Aoki T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S22-6. PubMed ID: 7594333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravenous lansoprazole: in erosive oesophagitis.
    Dando TM; Plosker GL
    Drugs; 2004; 64(18):2085-9; discussion 2090. PubMed ID: 15341501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Time to maximum effect of lansoprazole on gastric pH in normal male volunteers.
    Bell NJ; Hunt RH
    Aliment Pharmacol Ther; 1996 Dec; 10(6):897-904. PubMed ID: 8971286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of clarithromycin and amoxicillin on gastric emptying in rats.
    Endo H; Yoshida H; Kohno Y; Suga T
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3331-3. PubMed ID: 12234874
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of gastric secretion relieves diarrhea and postprandial urgency associated with irritable bowel syndrome or functional diarrhea.
    Dave B; Rubin W
    Dig Dis Sci; 1999 Sep; 44(9):1893-8. PubMed ID: 10505731
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lansoprazole versus omeprazole in active duodenal ulcer. A double-blind, randomized, comparative study.
    Ekström P; Carling L; Unge P; Anker-Hansen O; Sjöstedt S; Sellström H
    Scand J Gastroenterol; 1995 Mar; 30(3):210-5. PubMed ID: 7770708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of a proton pump inhibitor on postprandial gastric volume, emptying and symptoms in healthy human subjects: a pilot study.
    Grudell AB; Camilleri M; Burton DD; Stephens DA
    Aliment Pharmacol Ther; 2006 Oct; 24(7):1037-43. PubMed ID: 16984497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postprandial normal saline intake delays gastric emptying of solids in conscious dogs: partial involvement of CCK in its mechanism.
    Tanaka T; Mizumoto A; Muramatsu S; Mochiki E; Haga N; Suzuki H; Itoh Z
    Dig Dis Sci; 1999 Aug; 44(8):1516-24. PubMed ID: 10492127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does short-term treatment with proton pump inhibitors cause rebound aggravation of symptoms?
    Farup PG; Juul-Hansen PH; Rydning A
    J Clin Gastroenterol; 2001 Sep; 33(3):206-9. PubMed ID: 11500608
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury.
    Blandizzi C; Natale G; Gherardi G; Lazzeri G; Marveggio C; Colucci R; Carignani D; Del Tacca M
    Dig Dis Sci; 1999 Oct; 44(10):2039-50. PubMed ID: 10548356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of oral doses of lansoprazole and omeprazole on gastric pH.
    Tolman KG; Sanders SW; Buchi KN; Karol MD; Jennings DE; Ringham GL
    J Clin Gastroenterol; 1997 Mar; 24(2):65-70. PubMed ID: 9077718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.